Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 54.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,128 shares of the company's stock after selling 21,295 shares during the quarter. Raymond James Financial Services Advisors Inc.'s holdings in Bath & Body Works were worth $782,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Bath & Body Works by 0.3% in the third quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company's stock worth $868,307,000 after purchasing an additional 67,920 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Bath & Body Works by 1.0% during the 1st quarter. BlackRock Inc. now owns 17,074,153 shares of the company's stock worth $624,573,000 after acquiring an additional 174,915 shares during the last quarter. State Street Corp boosted its holdings in Bath & Body Works by 0.6% during the 3rd quarter. State Street Corp now owns 10,038,767 shares of the company's stock valued at $327,264,000 after acquiring an additional 58,201 shares during the period. Price T Rowe Associates Inc. MD grew its position in Bath & Body Works by 8.2% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company's stock valued at $171,326,000 after acquiring an additional 484,674 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Bath & Body Works by 2.3% during the first quarter. Geode Capital Management LLC now owns 4,725,145 shares of the company's stock worth $172,450,000 after purchasing an additional 106,263 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 1.2 %

Shares of BBWI stock traded down $0.52 during trading hours on Wednesday, reaching $43.17. 1,958,974 shares of the company's stock were exchanged, compared to its average volume of 2,781,343. The company has a market cap of $9.71 billion, a price-to-earnings ratio of 11.22, a P/E/G ratio of 1.45 and a beta of 1.86. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The stock's 50 day moving average is $46.20 and its 200-day moving average is $39.96.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.21. The company had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The firm's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.86 EPS. Equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 1.85%. The ex-dividend date of this dividend was Thursday, February 22nd. Bath & Body Works's dividend payout ratio is presently 20.78%.

Insider Buying and Selling at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the firm's stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.19% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on BBWI. BMO Capital Markets lifted their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the company an "outperform" rating in a report on Friday, March 1st. Telsey Advisory Group reiterated an "outperform" rating and issued a $53.00 price target on shares of Bath & Body Works in a report on Friday, April 5th. The Goldman Sachs Group raised their price objective on Bath & Body Works from $49.00 to $56.00 and gave the stock a "buy" rating in a report on Monday, March 4th. Piper Sandler upped their target price on Bath & Body Works from $44.00 to $45.00 and gave the stock a "neutral" rating in a report on Tuesday, April 9th. Finally, UBS Group raised their price target on Bath & Body Works from $46.00 to $52.00 and gave the company a "neutral" rating in a research note on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $46.33.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.